messag came away increment confid
compani take right step emerg crisi stronger
went current quarter like challeng believ
divers pipelin commit invest downturn posit
realiz improv momentum compani strong balanc sheet also
give margin error macro situat deterior someth
evid week rais dividend time sever peer
rais capit reiter buy rate pt
fiscal fourth quarter perform messi neg
impact four busi cvg suffer defer procedur
concert effort manag curtail quarter-end bulk purchas custom
dynam like amplifi hospit conserv cash april damag hospit
budget also weigh capit equip order depress rtg growth mitg
fare better quarter ventil sale help prop result diabet also
rel bright spot suppli stock help partial off-set slowdown new patient
start continu competit pressur manag expect gener trend
continu mitg diabet forecast grow corpor averag
cvg rtg lag
manag call revenu growth deceler sequenti strike us
conserv earli feedback may procedur volum encourag
china alreadi trend run rate partial off-set
increment weak western europ certain row countri howev view
manag direct commentari sale mostli reflect continu lack
visibl recoveri progress math suggest
compani like better current trajectori hold model call
organ revenu growth essenti line plan revisit
assumpt get clariti thing evolv next month two
volum could return pre-covid level current expect feb-
apr first quarter normal growth two-year stack basi
meanwhil believ pipeline-driven growth acceler stori led us
becom construct earlier year still larg intact micra
av strong start viru took hold grow february-march
see deep dive opportun manag expect sever key fda
approv quarter includ interstim micro percept pc db reveal linq one
product delay sound like launch domest
late calendar year earli meantim howev plan
roll pump essenti hardwar without advanc
close loop algorithm patient buy abl get algorithm
free via remot download approv complic launch think
improv user experi rel could still enough bolster
competit pump least margin near-term bigger
impact possibl data impress ada next month manag back
previous state goal time-in-rang studi
studi design perform pump continu
view best-in-class elsewher preclin develop hugo soft-tissu robot
enrol on-m trial also temporarili interrupt viru
disappoint given larg potenti opportun project address
see pipelin stori overli depend one program
sector medic suppli devic
page analyst certif import disclosur
adjust estim model call adjust ep
yoy total revenu cc compar prior forecast
respect model ep yoy
pre-covid project long-term continu see pathway
sustain top bottom-lin growth
product mention sever key growth driver enter fold
visibl growth outlook improv expect valuat
discount rel rest large-cap med-tech group narrow share
current trade ep estim meaning discount large-cap
med-tech averag see valuat gap line long-term growth
outlook compani believ roughli line broader group
averag price target base multipl forward
ntm ep estim signific upsid potenti target current level
reiter buy rate
page analyst certif import disclosur
wake covidien merger emerg largest med-tech
compani world boast lead franchis across wide varieti end market
sinc compani work translat unmatch scale competit
advantag strategi yield mix result howev growth
recent year lag behind rest large-cap med-tech group expect
chang longer term pipeline-driven growth acceler narrow perform
gap peer visibl enhanc growth outlook
improv impact becom clearer expect valuat gap
rest large-cap med-tech group close well drive
meaning upsid current level
share current trade ep estim
ebitda discount large-cap med-tech group averag
respect pipelin kick next month see growth
acceler top bottom line level roughli line broader
group averag visibl improv outlook increas full impact
becom clearer expect stock trade less discount large-
cap med-tech peer maintain price target base
previous multipl revis forward ntm ep estim reiter
buy rate
downsid risk rate price target includ clinic setback weaker-than-
expect adopt new product caus revenu fall short street estim
better-than-expect share gain competitor failur execut margin
page analyst certif import disclosur
million usd except
good sold
compani report guggenheim secur llc estim
page analyst certif import disclosur
million usd
compani report guggenheim secur llc estim
page analyst certif import disclosur
